IL6 and mucopolysaccharidosis type 2: Fujitsuka et al. (2019) measured for the first time eight biomarkers which were significantly elevated in untreated MPS II patients, compared to normal controls: EGF, IL-1β, IL-6, HS0S, HSNS, DS, mono-sulfated KS, and di-sulfated KS.